Biofrontera Ag Revenue Growth Rates (BFRA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Biofrontera Ag  (BFRA)
 

BFRA's Revenue Growth by Quarter and Year

Biofrontera Ag's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BFRA Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
4th Quarter December 23.64
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 23.64





BFRA Revenue fourth quarter 2018 Y/Y Growth Comment
Biofrontera Ag in the fourth quarter 2018 achieved Revenue of $ 23.64 millions compare to recorded in same quarter a year ago.

Looking into fourth quarter 2018 results within Major Pharmaceutical Preparations industry 73 other companies have achieved higher Revenue growth. While Biofrontera Ag' s Revenue no change of 0% ranks overall at the positon no. 572 in the fourth quarter 2018.


BFRA Revenue ( Y/Y Growth %) 2018
 2017 2016 2015
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Biofrontera Ag's fourth quarter 2018 Revenue $ 23.64 millions BFRA's Income Statement
Biofrontera Ag's fourth quarter 2017 Revenue $ 0.00 millions Quarterly BFRA's Income Statement


BFRA Revenue (Quarter on Quarter Growth %)

 2018
 2017 2016 2015
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Back to BFRA Growth rate Comparisons >> Back to BFRA Growth rate Comparisons >>


Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #74
Healthcare Sector #133
Overall #572

Revenue Y/Y Growth Statistics
High Average Low
48.05 % 23.49 % -1.07 %
(Dec 31 2019)   (Dec 31 2020)
Revenue fourth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #74
Healthcare Sector #133
Overall #572
Revenue Y/Y Growth Statistics
High Average Low
48.05 % 23.49 % -1.07 %
(Dec 31 2019)   (Dec 31 2020)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Biofrontera Ag's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BFRA's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BFRA's IV. Quarter Q/Q Revenue Comment


Biofrontera Ag's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Dec 31 2019)		 12 Months Ending
(Dec 31 2018)		 12 Months Ending
 12 Months Ending
Cumulative Revenue 12 Months Ending $ 34.63 $ 35.00 $ 23.64 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) -1.07 % 48.05 % - - -
Year on Year Revenue Growth Overall Ranking # 572 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) -1.07 % 48.05 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2020 Biofrontera Ag reported a decrease in Revenue by -1.07% year on year, to $35 millions, compare to the 48.05% growth at Dec 31 2019.

In the Healthcare sector 132 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 572.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 74
Healthcare Sector # 133
Overall # 572

Revenue TTM Y/Y Growth Statistics
High Average Low
48.05 %
 23.49 %
-1.07 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 74
Sector # 133
S&P 500 # 572
Cumulative Revenue growth Comment
For the 12 months ended Dec 31 2020 Biofrontera Ag reported a decrease in Revenue by -1.07% year on year, to $35 millions, compare to the 48.05% growth at Dec 31 2019.

In the Healthcare sector 132 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 572.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 74
Healthcare Sector # 133
Overall # 572

Revenue TTM Y/Y Growth Statistics
High Average Low
48.05 %
23.49 %
-1.07 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 74
Sector # 133
S&P 500 # 572




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BFRA's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Dec 31 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2018
Zimmer Biomet Holdings Inc -0.16%$ -0.159 millions
Tg Therapeutics Inc -0.25%$ -0.249 millions
Hanger inc.-0.31%$ -0.309 millions
Surgalign Holdings Inc -0.55%$ -0.546 millions
3m Company-0.56%$ -0.563 millions
Bio rad Laboratories Inc -0.72%$ -0.717 millions
Quest Diagnostics Inc-1.39%$ -1.394 millions
Biomarin Pharmaceutical Inc-1.42%$ -1.421 millions
Inspiremd Inc -1.44%$ -1.439 millions
Star Equity Holdings Inc -1.46%$ -1.459 millions
Prophase Labs Inc -1.47%$ -1.470 millions
Meridian Bioscience Inc -1.54%$ -1.536 millions
Sonida Senior Living Inc -1.60%$ -1.601 millions
Hca Healthcare Inc -1.78%$ -1.784 millions
Immune Design Corp.-1.86%$ -1.856 millions
Bausch Health Companies Inc -1.94%$ -1.942 millions
Opiant Pharmaceuticals Inc -2.21%$ -2.211 millions
Htg Molecular Diagnostics Inc-2.23%$ -2.227 millions
Invacare Holdings Corporation-2.31%$ -2.307 millions
Pediatrix Medical Group Inc -2.46%$ -2.458 millions
Gilead Sciences Inc -2.59%$ -2.589 millions
Dentsply Sirona Inc -2.87%$ -2.869 millions
Diversicare Healthcare Services Inc -3.26%$ -3.258 millions
Encision Inc -3.33%$ -3.326 millions
Orasure Technologies Inc-3.43%$ -3.425 millions
Alphatec Holdings Inc -3.58%$ -3.576 millions
Stereotaxis Inc -3.81%$ -3.806 millions
Sophiris Bio Inc.-3.85%$ -3.846 millions
Kaya Holdings Inc -4.21%$ -4.206 millions
Utah Medical Products Inc-4.36%$ -4.362 millions


About Biofrontera Ag Revenue Growth Rates (BFRA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.